ANALYSIS OF CLINICAL AND LABORATORY CHARACTERISTICS OF COVID-19 IN ELDERLY PATIENTS

Abstract

SUMMARY. A comparative analysis of clinical and laboratory indicators in patients over 60 years old (elderly people – the main group) and patients under 60 years old (comparison group) was carried out. It was determined that the severe course of the disease was observed regardless of age, but the fatal outcome occurred twice as often in elderly patients – 36 (20.0 %) versus 14 (10.0 %) cases in patients of the comparison group (p=0.015). It was determined that patients 60 years of age and older suffered from coronary heart disease significantly more often – 65 (36.1 %) versus 18 (12.9 %) patients of the comparison group; hypertension – 133 (73.9 %) versus 37 (26.4 %) younger patients (p<0.001); diabetes – 49 (27.2 %) versus 16 (11.4 %) patients of the comparison group (p<0.001). It was determined that patients 60 years of age and older suffered from coronary heart disease significantly more often – 65 (36.1 %) versus 18 (12.9 %) patients of the comparison group; hypertension – 133 (73.9 %) versus 37 (26.4 %) younger patients (p<0.001); diabetes – 49 (27.2 %) versus 16 (11.4 %) patients of the comparison group (p<0.001). Chronic diseases of the respiratory tract were also significantly more common in older patients – 9 (5.0 %) versus 1 (0.7 %) cases in the comparison group (p=0.029) and veins of the lower extremities – 6 (3.3 %) versus 0 % (p=0.037). Statistically significant differences between groups in terms of systolic and diastolic blood pressure (respectively p=0.002 and p=0.047), in the level of glucose (p=0.004), urea (p<0.001), urea nitrogen (p=0.005) in blood serum correspond to those somatic diseases that are more often observed in people 60 years of age and older and can have a marker role in determining the prognosis of the disease.